Since the lipid profile is altered by physical activity, the study of lipid metabolism is a
remarkable element in understanding if and how physical activity affects the health of both …

In obese individuals, atherogenic dyslipidemia is a very common and important factor in the
increased risk of cardiovascular disease. Adiposity-associated dyslipidemia is characterized …

Lipoprotein (a)[Lp (a)], aka “Lp little a”, was discovered in the 1960s in the lab of the
Norwegian physician Kåre Berg. Since then, we have greatly improved our knowledge of …

High-density lipoprotein (HDL) plays an important role in lipid metabolism and especially
contributes to the reverse cholesterol transport pathway. Over recent years it has become …

Ophthalmic epidemiology is concerned with the prevalence, distribution and other factors
relating to human eye disease. While observational studies cannot avoid confounding …

Hyperlipidaemia is a well‐established risk factor for cardiovascular diseases and therefore,
many animal model have been developed to mimic the human abnormal elevation of blood …

High-density lipoprotein (HDL) particles have experienced a turbulent decade of falling from
grace with widespread demotion from the most-sought-after therapeutic target to reverse …

Lowered high-density lipoprotein (HDL) cholesterol has been reported in major depressive
disorder, bipolar disorder, first episode of psychosis, and schizophrenia. HDL, its major …

Cardiovascular disease (CVD) continues to be a leading cause of death worldwide with
atherosclerosis being the major underlying pathology. The interplay between lipids and …

Aims The monocyte to high‐density lipoprotein cholesterol ratio (MHR) has emerged as a
novel inflammatory biomarker of atherosclerotic cardiovascular disease. However, it has not …